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A B S T R A C T
Depression in young adults is a growing concern to public health. This study aims to investigate if depression
status in young adults is related to clinical and behavioral cardiovascular disease (CVD) risk factors. Cross-
sectional data from a population-based sample of young Danish adults participating in the European Youth Heart
Study 2009–2010 were used to examine this (n= 644, mean age 24.3 years 47% male). Measures of cardior-
espiratory ﬁtness (CRF), body composition, blood pressure, fasting levels of high and low density lipids (HDL,
LDL), insulin, and glucose were obtained. Symptoms of depression were obtained using the Major Depression
Inventory scale. Information on sleep disorders; drinking and smoking habits were obtained by questionnaires.
Associations of depression with CVD risk factors were examined using logistic and linear regression adjusted for
age and sex. Prevalence of mild-moderate-severe depression was 8.7% (5.6% males, 11.5% females). Signiﬁcant
sex diﬀerences were found in the association between several CVD risk factors and depression status. Women
with depression had higher odds of overweight (OR=2.2, 95%CI: 1.01–4.0), abdominal adiposity (OR=2.5,
95%CI: 1.2–4.8), low CRF (OR=2.5, 95%CI: 1.2–5.5), insulin resistance (OR=2.3, 95%CI: 1.1–4.6), low HDL
(OR=2.0, 95%CI: 1.01–4.1) and high LDL (OR=2.2, 95%CI: 1.04–4.5) compared to women without de-
pression. Men with depression had signiﬁcantly increased odds of having high blood pressure and being smokers
compared to men without depression (OR: 3.1, 95%CI: 1.1–8.8 and OR: 3.0, 95%CI: 1.1–8.4, respectively).
Depression symptoms in young adulthood were related to unfavorable clinical- and behavioral CVD risk factors,
particularly in women.
1. Introduction
Depression is a common disorder and a growing challenge to public
health (Murray et al., 2015). It often starts at young age and it is the
principal cause of disability-adjusted life years lost among adolescents
and young adults worldwide (Gore et al., 2011). In middle- and older
adulthood depression is a major risk factor for development of cardio-
vascular diseases and type 2 diabetes (Van der Kooy et al., 2007; Pan
et al., 2011; Nouwen et al., 2010). However, individuals with cardio-
vascular disease and diabetes also have increased risk of depression and
a bidirectional association has been suggested (Nouwen et al., 2010;
Luppino et al., 2010). Also chronic medical conditions, alongside with
unhealthy lifestyle behaviors, have been shown to explain the
association between depression and cardiovascular disease (CVD)
mortality (Atlantis et al., 2012). While these relationships have been
studied extensively in middle-aged and older adults it remains less clear
if young people with depression are at greater risk of CVD or already
show indications of increased clinical and behavioral CVD risk factors.
One prospective cohort study (Shah et al., 2011) has shown that
clinically diagnosed depression in young adulthood is associated with
increased risk of coronary heart disease mortality during 15 years of
follow-up. Furthermore, there is some evidence that young people with
depression symptoms have poor cardiovascular health (Davidson et al.,
2000; Charlson et al., 2013; Dietz and Matthews, 2011) although most
studies have reported on single risk factors such as blood pressure
(Meng et al., 2012). Also, some studies have suggested that young
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people with symptoms of depression engage more in high risk health
behaviors such as smoking (Dierker et al., 2015) and excessive alcohol
consumption (Edwards et al., 2014) and that the relationships between
depression and CVD risk could be explained by such factors (Dietz and
Matthews, 2011; Katon, 2003; Ont. Health Technol. Assess. Ser., 2013).
Yet further studies are needed to clarify the extent to which young
adults with depression symptoms have greater prevalence of clinical
and behavioral CVD risk factors. In particular, studies in non-selected
general population samples are lacking.
The objective of this study therefore was to investigate the asso-
ciations between self-reported depression status and clinical CVD risk
factors and health behaviors in a random population sample of Danish
young adults.
2. Materials and methods
2.1. Study design and sampling of participants
This study is based on the Danish cohort of the European Youth
Heart Study (EYHS). EYHS is an ongoing, international, population-
based prospective observational multicenter study that addresses CVD
risk factors in children and adolescents. The participants in the EYHS
study was originally sampled in 1997/1998 at age 8–10 or 14–16 years
of age attending 3rd or 9th grade in schools located in the municipality
of Odense Denmark (the third largest community in Denmark). A de-
tailed description of the sampling procedure and the general methods
used in the EYHS can be found elsewhere (Riddoch et al., 2005). In brief
the children were randomly sampled through a two-stage cluster sam-
pling from schools stratiﬁed according to location (urban, suburban,
and rural) and socioeconomic character of its uptake area (high middle,
and low). The primary unit was the schools where 28 out of 35 eligible
schools were randomly sampled and 25 agreed to participate. A total of
1429 children and adolescents were randomly sampled on these schools
(N= 1018, 71,2% participated in 1997/1998). In 2009/10 the original
sample were re-invited to participate in a new wave. The present cross
sectional study is based on data obtained in 2009/2010 of n=650
young Danish adults (mean age 24.3 years, range: 20.8–28.8 years). The
eligible sample for the current analyses consisted of n=632 to n=644
individuals who had complete data depending on the exposure and
outcome variables used in the analysis, except for questionnaire on
alcohol consumption, where n=580 had complete data.
Ninety-six percentage of the population at baseline were white
(Caucasian).
The Regional Scientiﬁc Ethical Committee for Southern Denmark
(ID S-20090100) approved the study and all participants provided
written informed content.
2.2. Assessment of symptoms of depression
Symptoms of depression were assessed using the Major Depression
Inventory (MDI) scale (Bech et al., 2001). The MDI scale consists of ten
ICD-10 symptoms of depression and is based on the universe of symp-
toms in Diagnostic and Statistical Manual of Mental Disorders—Fourth
Edition (DSM-IV) major depression symptoms. The 10 symptoms are
based on 12 items (no. 8 and no. 10 are twofold) on a six-point Likert
scale (0 to 5) and each individual item measures how much time the
symptoms have been present during the past 14 days. The MDI ques-
tionnaire is self-reported and the individual is asked: The following
questions ask about how have you been feeling over the last two weeks.
Please put at tick in the box which is closest to how you have been
feeling. How much of the time have you: 1) felt low in spirits or sad? 2)
lost interest in daily activities? 3) felt lacking of energy and strength? 4)
felt less self-conﬁdent? 5) had a bad conscience or feeling guilt? 6) felt
life wasn't worth living? 7) had diﬃculty in concentrating, e.g. when
reading the newspaper or watching television? 8a) felt very restless?
8b) felt subdued? 9) had trouble sleeping at night? 10a) suﬀered from
reduced appetite? 10b) suﬀered from increased appetite? Zero on the
scale indicates that the symptom has not been present at all and ﬁve
that the symptom has been present all of the time (Bech et al., 2001).
The questionnaire is available in diﬀerent languages from https://
www.psykiatri-regionh.dk/CCMH/Rating-scales-og-spoergeskemaer/
Sider/default.aspx.
We scored and classiﬁed individuals according to published guide-
lines (Bech et al., 2001): 1) mild, moderate or severe depression
(MDI≥ 20) or 2) DSM-IV major depression. The MDI scale has been
reported to have a high degree of agreement with the Schedule for
Clinical Assessment in Neuropsychiatry tool and the Hamilton Depres-
sion Scale (Bech et al., 2001; Olsen et al., 2003). Due to a relatively low
number of individuals with symptoms of depression we were unable to
further sub-divide participants into mild, moderate, and severe de-
pression for analyses. There for prevalence of Major Depression ac-
cording to DSM-IV is only presented in Table 1 and not used in further
analysis.
2.3. Assessment of other covariates
Body height and body weight were assessed using standard an-
thropometric procedures by trained research staﬀ, and body mass index
(BMI) was calculated.
Waist circumference was measured twice with a metal anthropo-
metric tape midway between the lower rib margin and the iliac crest, at
the end of a gentle expiration. The mean value of the two measurements
was used for analysis.
Resting (sitting 5min prior to measurement) systolic and diastolic
blood pressure were measured in the sitting position using the in-
dividuals left arm, with a Dinamap vital signs monitor (model XL,
Critikron, Inc., Tampa, FL). Five measurements were taken at 2-min
intervals. The mean of the last three measurements was used for ana-
lysis.
Blood sampling and analysis: Fasting (overnight) blood samples
were taken at the beginning of the day from the antecubital vein. Blood
samples were aliquoted and separated within 30min of venepuncture
and samples were stored at−80 °C until transported to a WHO-certiﬁed
laboratory for analysis.
Total cholesterol, high density lipoprotein cholesterol (HDL-C), and
triglyceride (TG) were measured by enzymatic methods. Glucose was
analyzed by the hexokinase method. Each of these was measured on an
Olympus auto analyser (model AU600, Olympus Diagnostica GmbH,
Hamburg, Germany). Low-density lipoprotein cholesterol (LDL-C) was
calculated using the Friedwald equation (Friedewald et al., 1972).
Abdominal obesity, overweight and obesity, hypertension, hyper-
triglyceridemia, hypercholesterolemia, low HDL and glucose
Table 1
Depression score and prevalence rates of mild, moderate, severe and major
depression.
Data obtained
2009–2010
Mean MDI
score (SD)
Prevalence rates (%) (95%CI)
Any signiﬁcant
depression
(MDI≥ 20)
DSM-IV major
depression
Total population
(n= 644)
8.6 (7.4) 8.7 (6.7–11.1) 4.2 (2.9–6.1)
Men (n=304) 7.4 (6.6)a 5.6 (3.4–8.8)a 2.0 (0.9–4.3)a
Women (n=340) 9.7 (8.0)a 11.5 (8.5–15.3)a 6.2 (4.1–9.3)a
21-year olds
(n= 366)
9.1 (7.5) 9.0 (6.5–12.4) 4.9 (3.1–7.7)
27-year olds
(n= 278)
8.0 (7.2) 8.3 (5.6–12.2) 3.2 (1.7–6.1)
MDI=Major Depression Inventory, DSM-IV=Diagnostic and Statistical
Manual of Mental Disorders—Fourth Edition.
a Signiﬁcant diﬀerence between gender.
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impairment were deﬁned according to Third Report of the National
Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation and Treatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III) (Circulation, 2002). As a measure for insulin re-
sistance a HOMA-IR score was calculated from fasting glucose and
fasting insulin ((Insulin pU/ml ∗ glucose mmol/l) / 22.5) (Matthews
et al., 1985). As no internationally recognized cut points are established
for insulin resistance a cut point for having altered risk of insulin re-
sistance was set at belonging to the highest sex-speciﬁc quartile of the
HOMA-IR score.
Cardiorespiratory ﬁtness was assessed directly using a maximal
exercise test on a cycle ergometer (Monark 839E, Varberg, Sweden).
The test started with a ﬁve-minute warm-up at 75W (women) or 100W
(men) and the work-load was subsequently increased by 35W every
3min until exhaustion (participants were verbally encouraged to con-
tinue for as long as possible as described by the American College of
Sports Medicine (2010) as a good criteria measure). During the test,
pulmonary oxygen uptake (VO2), expired carbon dioxide (CO2), and
pulmonary ventilation were analyzed using indirect calorimetry (AMIS
2001, Innovision, Odense Denmark). The respiratory exchange ratio
(RER) was estimated as expired CO2/VO2. Maximal VO2 consumption
(VO2-max) was estimated as the average of VO2 during the last 15 s of
the test divided by body weight. Heart rate (HR) was measured con-
secutively during the test using a Polar HR monitor (RS800, Kempele,
Finland). Individuals were excluded if subjective assessment of ex-
haustion were not met (considered “not reached” by tester), unless
RER>1.1 or HR>85% of age predicted HR max (220-age (years)) at
the end of the test.
Data on smoking, drinking and sleeping habits were obtained from
questionnaires. Participants were asked: “Do you smoke?” There were
six possible categories of answers: 1) Yes, daily, 2) Yes, at least once a
week, 3) Yes, at least once a month, but not every week, 4) Yes, but less
than once a month, 5) No, I quit, 6) No, I never smoked. For analysis
participants were deﬁned as smokers if they had answered 1) Yes, daily,
2) Yes, at least once a week.
For alcohol consumption participants were asked to ﬁll in how
many units of alcohol they typically would consume on every day of the
week. For analyses the amount of daily units were summed up and a
dichotomous variable were constructed deﬁning whether participants
met the recommendations by the national guidelines (men < 21,
women < 14 units per week) or not. Sleep disorder was assessed by
asking: “How often do you experience bad or uneasy sleeping?”
Possible answers were: 1) every or almost every night, 2) Several times
a week, 3) Several times a month, 4) Several times a year, 5) Never. For
analysis participants were deﬁned as having “sleep disorder” if the
answer was 1) or 2).
2.4. Statistical analysis
The associations of CVD risk factors with depression score were
examined using linear or logistic regression analyses adjusted for age
and sex. We examined the possibility that the associations of CVD risk
with symptoms of depression would be diﬀerent between men and
women by including an interaction term between sex and depression
including main eﬀects as covariates. As interaction was evident for
several of the CVD risk factors (waist circumference, triglycerides and
glucose, p-values < 0.03) we also examined associations stratiﬁed by
sex.
Although we a priori identiﬁed ethnicity as a confounding variable
it was not considered in the analyses because 96% of the study popu-
lation was white. Standard linear regression diagnostics were ex-
amined, including examining linearity and normality of residuals, and
for most variables the examination revealed no indication of violation,
but triglycerides, glucose and HOMA-IR was log transformed to meet
the assumptions. For the outcomes that were log transformed we ex-
ponentiated the regression coeﬃcients and presented them as ratio of
the geometric means expressed in percentage. All statistical analyses
were performed in STATA 14 with alpha=0.05 (two-sided).
3. Results
Prevalence of mild-moderate-severe depression was 8.7% (5.6%
Table 2
Cardiovascular risk factors of participants with and without symptoms of depression.
Variable Depresseda
N=56 (30,4%
males)
Crude mean (SD)
Nondepresseda
N=574–588 (48.8%
males)
Crude mean (SD)
Mean diﬀerence in risk factor by
depression statusa
Gender speciﬁc mean diﬀerence in risk factor by
depression statusa
All
N= 628–644
Women
N=328–340
Men
N=293–304
Mean diﬀerence
(95%CI)
p-Value Mean diﬀerence (95%CI)
Age, years 24.2 (3.1) 24.3 (3.0) Age and gender adjusted Age adjusted diﬀerences
BMI, points 25.2⁎ (5.2) 24.1⁎ (3.8) 1.3⁎ (0.2–2.4) 0.02 1.7⁎ (0.3–3.1) 0.3 (−1.5–2.1)
Waist circumference, cm 81.7 (13.0) 80.7 (10.6) 2.5 (−0.4–5.3) 0.09 4.8⁎ (1.5–8.0) −2.4 (−7.7–2.8)
Systolic blood pressure, (mmHg) 115.6 (11.5) 114.7 (10.4) 2.7⁎ (0.1–5.2) 0.04 1.6 (−1.3–3.8) 4.8⁎ (0.01–9.6)
Diastolic blood pressure, (mmHg) 71.3 (7.9) 69.4 (7.9) 2.2⁎ (0.05–4.4) 0.04 1.3 (−1.3–3.8) 4.0⁎ (0.03–7.9)
Glucose, (mmol/l)
Glucoselog (%)
5.3⁎ (1.6) 5.0⁎ (0.5) 0.3⁎ (0.1–0.5)
0.04⁎ (0.01–0.07)
0.001 0.4⁎ (0.2–0.7)
5.8⁎ (2.1–9.3)
0.003 (−0.2–0.2)
0.2 (−4.4–4.7)
HOMA-IR
(Insulin p μU/ml ∗ glucose
mmol/l) / 22.5
HOMAlog (%)
1.8⁎ (1.5) 1.4⁎ (1.0) 0.4⁎ (0.08–0.6)
19⁎ (3.0–34.6)
0.01 0.4⁎ (0.03–0.7)
26.4⁎ (8.3–44.5)
0.4 (−0.1 to 0–9)
1.7 (−27.9–31.2)
Total cholesterol, (mmol/l) 4.7 (0.9) 4.6 (0.9) 0.10 (−0.1–0.3) 0.8 0.18 (−0.1–0.5) −0.1 (−0.5–0.3)
HDL, (mmol/l) 1.4 (0.4) 1.4 (0.4) −0.07 (−0.2–0.02) 0.1 −0.1 (−0.2–0.01) −0.01 (−0.2–0.2)
LDL, (mmol/l) 2.8 (0.7) 2.7 (0.8) 0.08 (−0.1–0.3) 0.5 0.13 (−0.13–0.4) −0.1 (−0.4–0.3)
Triglycerides, (mmol/l)
Triglycerideslog (%)
1.4⁎ (0.4) 1.2⁎ (0.6) 0.2 (0.02–0.35)⁎
16 (3.8–28.2)⁎
0.03 0.3⁎ (0.14-0.5)
26 (12.3–39.7)
−0.1 (−0.4 to 0.2)
−5.7 (−28.8 to 17.4)
Fitness, (mlO2/min/kg) 35.2⁎ (9.2)
N=55
39.4⁎ (8.5) −2.9 (−5.2 to −0.6)⁎ 0.015 −3.8⁎ (−6.4 to −1.1) −0.9 (−5.2 to 3.3)
Varying N is explained by N=574–577 for blood samples and N=571 ﬁtness for non-depressed and by N=55 for ﬁtness for depressed.
a Mild, moderate or severe depression (MDI≥ 20).
⁎ signiﬁcant diﬀerence between depressed/nondepressed (p≤ 0.05).
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males, 11.5% females). Prevalence of major depression was 4.2% (2.0%
males, 6.2% females) (Table 1). Several mean values of single risk
factors were signiﬁcantly higher for individuals with symptoms of mild
to severe depression compared to individuals with no symptoms
(Table 2).
Age and sex adjusted mean diﬀerence in CVD risk factors between
depressed and non-depressed were signiﬁcant for BMI (β=1,3 kg/m2
95%CI: 0.2–2.4), triglycerides (β=0.19mmol/L, 95%CI: 0.02–0.35,
triglycerideslog 16%, 95%CI: 3.8–28.2), blood pressure (systolic:
β=2.7mmHg, 95%CI: 0.13–5.2, diastolic: β=2.2mmHg, 95%CI:
0.06–4.8), glucose (β=0.3mmol/L 95%CI: 0.12–0.47, glucoselog 4%,
95%CI: 1.0–7.0), logHOMA-IR (β=19%, 95%CI: 3.0–34.6) and CRF
(β=−2.9ml/O2/min/kg, 95%CI: −5.2 to −0.6). Sex stratiﬁed ana-
lysis conﬁrmed sex-discordant associations of depression with biolo-
gical risk factors; women with depression symptoms had raised BMI,
waist circumference, glucose, HOMA-IR and triglycerides and low ﬁt-
ness compared to women without depression. In men with depression
symptoms only blood pressure was signiﬁcantly raised compared to
non-depressed men (Table 2).
Table 3 shows the prevalence and odds of being at risk deﬁned by
sex speciﬁc international guidelines for each risk factor (or by dis-
tribution if no international guidelines were available) including the
odds of risk behavior according to smoking, drinking and having sleep
disorders. Women with symptoms of depression had increased odds of
overweight (BMI: OR=2.0, 95%CI: 1.002–4.0, WC: OR=2.5, 95%CI:
1.2–4.8), of having levels of HOMA-IR at or above the 75th sex speciﬁc
percentile of (OR=2.3, 95%CI: 1.1–4.6), raised levels of triglycerides
(OR=3.4, 95%CI: 1.6–7.4) and low CRF (OR=2.5, 95%CI: 1.2–5.5)
compared to women without symptoms of depression. For men with
depression symptoms only odds of having high blood pressure was
signiﬁcantly increased compared to men without depression (OR=3.1,
95%CI: 1.1–8.7).
The odds ratio of being a smoker were raised for young men with
symptoms of depression compared to young men without symptoms of
depression (OR=3.0, 95%CI: 1.1–8.4) but not for women. The odds
ratio of drinking more than recommend by national guidelines were not
signiﬁcantly raised for men and women with symptoms of depression
compared to men and women without symptoms of depression,
whereas both men and women had signiﬁcantly higher odds of ex-
periencing disturbed sleep compared to their counterparts with no
symptoms of depression (for men OR=18.0, 95%CI: 6.1–52.6, for
women OR=7.1, 95%CI: 3.5–14.5) (Table 3).
More than 60% of the depressed young adults reported having three
or more risk factors elevated. This proportion was 36% among non-
depressed. The association of symptoms of depression score with the
number of elevated risk factors is presented in Fig. 1. Logistic regression
showed that having three or more risk factors elevated was associated
with greater odds of having symptoms of depression (OR=2.7, 95%CI:
1.5–4.8). For depressed women the odds ratio for having raised levels of
three or more CVD risk factors was as high as 4.0 (95%CI: 2.0–8.3)
compared to women without depression. For men this diﬀerence was
not signiﬁcant (Fig. 2).
4. Discussion
In this population-based study we found that Danish young adults
Table 3
Prevalence rates and odds ratios of clinical cardiovascular risk factors and risk behaviors (smoking, drinking and sleep disorders) by depression status.
“At risk”a variable Depressedb
N=47–56 (30,4%
males)
Nondepressedb
N=529–588 (48.8%
males)
All
N=595–644
Odds ratios for being “at risk”a by depression statusb
Prevalence rates % (n) (95%CI) Women
N=328–340
Adjusted for age
Men
N=302–304
Adjusted for age
All adjusted for age and
gender
OR (95%CI)
Overweight or obesity 41.1 (23) (29.0–54.4) 32.8 (193) (29.1–36.7) 33.6 (216)
(30.0–37.3)
2.0⁎ (1.002–4.0) 1.0 (0.4–2.8) 1.6 (0.0–2.8)
Abdominal adiposity 41.1⁎ (23) (29.0–54.4) 22.0⁎ (129) (18.8–25.6) 23.9 (152)
(20.8–27.4)
2.5⁎ (1.2–4.8) 1.7 (0.5–5.5) 2.2⁎ (1.2–3.9)
Hypertension 14.3 (8) (7–26) 9.0 (50) (6.5–11.1) 8.9 (58) (7.0–11.4) 2.4 (0.5–11.9) 3.1⁎ (1.1–8.7) 2.8⁎ (1.2–6.8)
Impaired fasting glucose 12.5 (7) (6.1–24.1) 11.6 (67) (9.2–14.5) 11.6 (74) (9.3–14.3) 2.4 (0.8–6.8) 0.6 (0.1–2.8) 1.4 (0.6–3.2)
Insulin resistance 37.5 (21) (25.8–50.9) 23.7 (136) (20.4–27.4) 25 (157) (21.6–28.4) 2.3⁎ (1.1–4.6) 1.3 (0.5–4.0) 1.9⁎ (1.1–3.5)
Hypercholesterolemia, 35.7 (20) (24.2–49.1) 24.6 (142) (21.2–28.3) 25.8 (162)
(22.6–29.4)
1.8 (0.9–3.5) 0.7 (0.2–3.1) 1.5 (0.8–2.7)
Low HDL 35.7 (20) (24.2–49.1) 27.2 (157) (23.7–31.0) 28 (177) (24.7–31.6) 2.0⁎ (1.01–4.1) 0.9 (0.3–2.7) 1.6 (0.9–2.8)
High LDL 28.6 (16) (18.2–41.8) 18.1 (104) (15.2–21.5) 19.2 (120)
(16.3–22.4)
2.2⁎ (1.04–4.5) 1.0 (0.3–3.7) 1.8 (0.9–3.3)
Hypertriglyceridemia, 23.2 (13) (13.9–36.1) 12.7 (73) (10.2–15.6) 13.6 (86) (11.2–16.5) 3.4⁎ (1.6–7.4) 0.4 (0–05-3.0) 2.1⁎ (1.1–4.1)
Low ﬁtness 35.6 (16) (22.9–50.6) 20.9 (115) (17.7–24.5) 22.0 (131)
(18.7–25.4)
2.5⁎ (1.2–5.5) 1.3 (0.4–4.3) 2.0⁎ (1.1–3.9)
Regular smoker 44.6 (25) (32.1–57.9) 32.6 (191) (28.9–36.5) 33.7 (216)
(30.2–37.4)
1.4 (0.7–2.9) 3.0⁎ (1.1–8.4) 1.9 (1.1–3.3)
Drinking, > recommendations 17.1 (8) (8.7–30.7) 17.2 (91) (14.2–20.7) 17.1 (99) (14.2–20.4) 0.9 (0.3–2.9) 1.4 (0.4–4.5) 1.1 (0.5–2.5)
Sleep disorder 60.7⁎ (34) (47.3–72.7) 13.3⁎ (78) (10.8–16.3) 17.4 (112)
(14.7–20.6)
7.1⁎ (3.5–14.5) 18⁎ (6.1–52.6) 9.6⁎ (5.2–17.4)
Varying N is explained by N=574–577 for blood samples, N=571 ﬁtness N=586 for smoking regularly, N=587 for sleep disorder and N=529 for risk of
drinking > recommendations for the nondepressed, and by N=55 for ﬁtness and N=47 for drinking disorder for depressed.
a According to international guidelines; deﬁned at risk if: Overweight or obese (≥25 BMI (kg/m2)), Abdominal adiposity (male: WC≥ 94 cm, female:
WC≥ 80 cm), Hypertension: systolic BP≥ 130mmHg or diastolic BP≥ 85mmHg, Glucose impairment: fasting glucose≥ 5.6 mmol, Insulin resistance: (HOMA-
IR)≥ 75 sex-speciﬁc percentile of the population Hypercholesterolemia > 200mg/Dl, Low HDL: cholesterol < 1.03mmol/l (men) and < 1.29mmol/l (women),
High LDL: cholesterol > 130mg/dl, Hypertriglyceridemia > 1.7mmol/l, Low Fitness: lowest sex-speciﬁc quartile of ﬁtness (mlO2/min/kg), Smoker: currently
smoking every week or more, Drinking: more than national recommendations; men < 21, women < 14 units per week, Sleep disorder: having experienced restless
or bad sleep several times a week/almost every night.
b Mild, moderate or severe depression (MDI≥ 20).
⁎ Signiﬁcant diﬀerence between depressed/nondepressed (p≤ 0.05).
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with any signiﬁcant depression had greater prevalence of several clin-
ical- and behavioral CVD risk factors compared with non-depressed
individuals. These associations were generally greater for women
compared to men. Other studies have shown these associations in
middle- and older adulthood, but the current study shows that this
unfavorable CVD risk proﬁle are already present in early adulthood in
individuals with symptoms of depression. Our ﬁndings suggest that
young people, in particular women, with depression needs special at-
tention regarding support for life style changes to prevent later CVD
and other metabolic disturbances such as type 2 diabetes.
The prevalence of depression found in this study is in line with
previous ﬁndings in a Danish population (Olsen et al., 2004) aged
20–79 years. In this large cross sectional study (n=1123), based on
data obtained by postal questionnaire in 2000, prevalence of any de-
pression (MDI≥ 20) was estimated to 7.1% and mean score of MDI was
7.2 in the total population. But when looking at a similar age group
(20–34 years) in the study by Olsen et al. (2004), prevalence rates of
depression were 8.8% and mean score of MDI 8.9, which equals the
prevalence rates in our study (8.7% and mean score of MDI at 8.6).
Similar to our study, Olsen and colleagues observed higher prevalence
rates and mean scores in women compared to men. In our study women
had signiﬁcantly higher prevalence of major depression compared to
men. Put together these two Danish studies indicate that symptoms of
depression appear more often at young age compared to older age and
in women compared to men. In our study, the sex-stratiﬁed analyses are
limited by the relative small numbers of cases with depression symp-
toms, which aﬀects the precision of the estimated diﬀerences in CVD
risk factor levels by depression status.
A study by Rhee et al. (2014) supports our ﬁndings of a sex speciﬁc
relationship of depression with CVD risk factors. In this Korean study,
comprising>30,000 adults (mean age years (SD): 47.5 (10.7) for de-
pressed individuals and 47.1(10.4) for non-depressed individuals), they
found that depressed women had increased odds of having metabolic
syndrome but no relationship was found among men. In contrast to
that, and our ﬁndings, they found that depressed men had signiﬁcantly
lower blood pressure than men without depression. We found that men
with symptoms of depression had greater prevalence of raised blood
pressure, though the conﬁdence intervals were wide. Our results on
blood pressure are supported by ﬁndings in a meta-analysis conducted
by Meng et al. (2012) including n= 22,367 adults (age range in nine
studies 12–75 years, most studies in middle aged 25–64 years) with a
mean follow-up period of 9.6 years. They showed that depression in
adulthood is independently associated to hypertension (Meng et al.,
2012). However, they did not stratify the analysis by sex. In addition,
our study found that hypertension is more prevalent in young men with
depression symptoms compared to men without depression. This sex
diﬀerence was also observed in the Cardiovascular Risk in Young Finns
Study (Elovainio et al., 2005). In this study Elovainio et al. (2005) also
reported that for men, but not for women, depressive symptoms during
early adulthood were associated with higher levels of carotoid intima-
media thickness. In a longitudinal study by Dietz and Matthews (2011),
with N=157 adolescents aged 16–21 years the association between
depression and intima-media thickness was not shown. The observed
association of depression and overweight/obesity in women is sup-
ported by several longitudinal studies (Luppino et al., 2010; Liem et al.,
2008; Rottenberg et al., 2014). We also found higher prevalence of
smoking, low ﬁtness and sleep disturbances among young adults with
Fig. 1. Association of depression score with number of
raised biological cardiovascular risk factors by gender.§
Circles represent mean. Vertical bars represents 95%CI.
Estimates are adjusted for age and gender. N= 340 (men)
N=344 (women). Danish data 2009–2010.
§Raised biological risk factors deﬁned from gender spe-
ciﬁc cut-points (see Materials and methods section): body
mass index, waist circumference, total cholesterol, LDL,
HDL, glucose, blood pressure or ﬁtness.
Fig. 2. Odds of having three or more clinical cardiovascular risk factors by
depression status.
*Risk factor deﬁned by gender speciﬁc cut-points from international guidelines
for each risk factor (body mass index, waist circumference, total cholesterol,
LDL, HDL, glucose, blood pressure or ﬁtness) (see Materials and methods sec-
tion).
N=644, depressed: N=56 (30,4% males), non-depressed: N=588 (48.8%
males). Danish data 2009–2010.
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depression symptoms. Though conﬁdence intervals were large and
cases with depression relatively low, these ﬁndings of behavioral risk
factors are in line with ﬁndings in other studies (Olsen et al., 2004;
Rottenberg et al., 2014).
A plausible explanation for the observed sex diﬀerence could be that
the autonomic function is altered diﬀerently in males and females with
major depression, as suggested in a cross sectional study by Voss et al.
(2011) where they observed a sex-dependent relationship of major
depression with autonomic cardiovascular modulation among 36 pa-
tients with major depression and 36 matched controls. The pronounced
diﬀerences in the relationship of depression with CVD risk factors
across sex suggests that young women with depression are at greater
risk of developing CVD and type 2 diabetes compared with men.
The results of this study should be interpreted in the light of some
limitations. Firstly, the cross-sectional design prevents us from pointing
to any causal pathway or direction in the relationship between de-
pression and CVD risk factors. Secondly, data on depression was self-
reported and not clinically diagnosed by professionals, this might have
led to an overestimation (Seldenrijk et al., 2015). Also data on smoking,
drinking, and sleeping were self-reported, which makes data prone to
both over and under reporting. The data on alcohol consumption was
the question where most young people (12%) did not give complete
answers, yet, the majority of missing answers were among the non-
depressed participants (87%). Last but not least it is a limitation that
the absolute number of participants with any depression was low in this
cohort, which might have underpowered some of the sub-group ana-
lysis and also made it impossible to divide symptoms of depression into
further sub-groups for analysis.
Strength of this study includes the population-based random sample
of healthy young adults. Because depressed and non-depressed parti-
cipants in our study were from the same source population the possi-
bility of selection bias in less likely to have inﬂuenced our comparisons
of CVD risk factors. To our knowledge no other studies have in-
vestigated the associations between symptom of depression and several
clinical and behavioral CVD risk factors in a similar population in one
study, but on single risk factors (Meng et al., 2012), proxy measures
(Meng et al., 2012) for risk factors and on mortality (Shah et al., 2011)
or an older population (Ont. Health Technol. Assess. Ser., 2013; Rhee
et al., 2014). Furthermore, the random sample of young individuals is
likely to be less confounded, than an older population with more co-
morbidity and medication use that may distort the relationship (Shah
et al., 2011). Yet, it is unknown if our comparisons of Danish young
adults with and without depression symptoms are generalizable to
populations in other countries.
In summary, our study conducted in a population-based cohort of
Danish young adults suggest that depression symptoms at this age is
associated to several unfavorable CVD risk factors, that are known to
predict early morbidity and mortality in later life (Pan et al., 2011;
Shah et al., 2011; Haukkala et al., 2009). Furthermore, we found that
women with depression symptoms were particularly likely to have
raised levels of biological CVD risk factors, which suggest that depres-
sion may increase the risk of later CVD more strongly in women com-
pared with men.
4.1. Perspectives and practical implications
Public health is challenged by high prevalence of depression in
young adults. Depressed adults suﬀer more often from chronic diseases
than non-depressed adults (Ont. Health Technol. Assess. Ser., 2013)
and>80% of depressed adults report their depression to be untreated
by a doctor (Olsen et al., 2004). At present, there is no evidence that
screening and treating for depression in adult populations improves the
symptoms of chronic diseases or lead to use of fewer health care ser-
vices (Ont. Health Technol. Assess. Ser., 2013). In that perspective our
results underline the importance of simultaneously focusing on beha-
vioral risk factors when dealing with young people with symptoms of
depression to prevent increasing CVD risk, co-morbidity and mortality
(Shah et al., 2011; Atlantis et al., 2012), especially in young women.
Longitudinal studies providing evidence of causality between risk
factors and depression are warranted as well as longitudinal studies
evaluating interventions integrating physical and behavioral health.
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